Purchase Order 75N92024P00136
Award Date 4/15/24
Potential Completion Date 10/15/24
Potential Value $42K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Kent, WA 98032, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the National Institute of Dental and Craniofacial Research (NIDCR), a civilian agency within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $24,994.77 firm-fixed-price purchase order, awarded on November 6, 2019, is for the delivery of STEMDIFF APEL 2 MEDIUM, a specialized cell culture product used to support biomedical research initiatives. Stemcell...
- This federal contract award, valued at $4,356.00, was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The contract is a Firm Fixed Price Purchase Order that runs through October 18, 2024. Stemcell Technologies Inc. is not a small business set-aside, but the company has been awarded some small business set-aside contracts in the past, indicating flexibility in its contracting status. Stemcell Technologies...
- Stemcell Technologies Inc. was awarded a firm fixed price purchase order valued at twenty-four thousand eight hundred eighty dollars and sixty-two cents ($24,880.62) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging on September 17, 2019. The award has no set-aside designation. Stemcell Technologies Inc. is a subsidiary of Stemcell Technologies, a Canadian company that develops cell culture media, separation systems, and other life sciences...
- Stemcell Technologies Inc., a Canadian biotechnology company, was awarded a $7,485 firm-fixed-price purchase order contract (HHSN272201100756P) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, which does not have a small business set-aside, was awarded on August 10, 2011 with a completion date of July 30, 2012. Stemcell Technologies Inc. primarily...
- This federal contract award to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies, is for the delivery of semi-solid culture media. The contract has a ceiling value of $24,664.00 and is a firm fixed price purchase order. The award is set aside for small businesses. Stemcell Technologies Inc. is a key supplier of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives...
- This is a federal purchase order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), which is part of the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada with a registered entity in the United States. The $34,255.58 firm fixed-price contract is for the provision of media for the growth and maintenance of human pluripotent stem cells and induced pluripotent...
- This federal contract award was issued by the National Institutes of Health (NIH) Clinical Center to Stemcell Technologies Inc., a subsidiary of the Canadian company Stemcell Technologies. The $10,313.00 Firm Fixed Price contract is for the provision of a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various NIH institutes and centers. Stemcell Technologies Inc. holds a single-award...
- This federal contract award was granted to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies, by the Department of Health and Human Services (HHS). The contract, worth $24,908.80, is a firm fixed-price purchase order for the company to provide a range of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various HHS agencies, including the...
- Stemcell Technologies Inc. has been awarded a firm fixed-price purchase order valued at $19,430.40 by the NIH Clinical Center, with an ultimate completion date of December 19, 2026. The contract, which carries no small business set-aside designation, will be performed in Kent, Washington. As a subsidiary of the Canadian biotechnology company Stemcell Technologies, the awardee specializes in providing advanced biological research products and laboratory supplies essential to federal research...
- This is a $6,493.50 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company specializing in cell culture media, cell separation systems, and other life sciences research products. The contract is not set aside for small businesses. Stemcell Technologies Inc. primarily acts as a prime contractor, providing a range of biological materials, laboratory supplies, and specialized...